• mk2 Biotechnologies
  • Am Klopferspitz 19
  • 82152 Planegg/Martinsried
  • Germany
  • Phone: +49 160 777 0880
mk2 Management

Dr. Konstantinos Antonopoulos, Co-Founder & Managing Director

Dr. Sebastian Mangold, Co-Founder & Managing Director

Dr. Marco Giuman, Co-Founder & Managing Director

About mk2 Biotechnologies

mk2 Biotechnologies develops, produces and investigates peptides at highest purity and quality standards using a revolutionary scalable synthesis technology. We are able to synthesize any kind of authentic peptide, regardless of its physical or chemical properties. This includes arbitrary chain length, charge, polarity and hydrophobicity. For this reason, we are strongly convinced that our process has the potential to tackle parts of major social challenges as well as to provide solutions for a known and yet unknown demand for new classes of active substances.

What is your motivation?

Future challenges cannot be overcome simply by an incremental improvement of today’s technology. Facing the yet unknown threats of the next 100 years urgently demands open-minded thinking, radical new ideas and revolutionary technologies. We are strongly convinced, that we do not only have the right technology, but also the right team to biologically contribute to coping with future challenges.

“We are excited to be part of the fruitful IZB ecosystem; a great foundation to achieve our big goals.”

Dr. Konstantinos Antonopoulos, Co-Founder & Managing Director
Dr. Sebastian Mangold, Co-Founder & Managing Director
Dr. Marco Giuman, Co-Founder & Managing Director